Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot)

Langerhans cell histiocytosis (LCH) is the most frequent type of histiocytosis and is characterized by both “inflammation/immune dysregulation” and “neoplastic disorder.” Although overall survival has remarkably improved through consecutive previous studies, the relapse-free survival rate is still o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Kenichi, Kikuchi, Kayoko, Sako, Mayumi, Kato, Miho, Takimoto, Tetsuya, Shioda, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771280/
https://www.ncbi.nlm.nih.gov/pubmed/36550910
http://dx.doi.org/10.1097/MD.0000000000031475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771280/
https://www.ncbi.nlm.nih.gov/pubmed/36550910
http://dx.doi.org/10.1097/MD.0000000000031475

Ejemplares similares